Trial Profile
Phase II trial of amrubicin and cisplatin chemotherapy for invasive thymoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 31 Jan 2019
Price :
$35
*
At a glance
- Drugs Amrubicin (Primary) ; Cisplatin (Primary)
- Indications Thymoma
- Focus Therapeutic Use
- 25 Jan 2019 Status changed from active, no longer recruiting to completed.
- 02 Jun 2011 New trial record